← Signals · Energy · TSXV
$STND
Standard Uranium Ltd.
Signal as of N/A  ·  90-day rolling window  ·  Other Energy Sources
Confluence Score
out of 100  ·  Full breakdown →
Score delayed 7 days on Free  ·  See today's score — Analyst →
Signals scoring 20–39 have historically hit 47% of the time (avg +6.8% over 90 days, 105 backtested signals). Methodology →
🔒 Risk monitoring — insider-selling & reversal warnings (Analyst)
Confluence Score
Insider Activity (90d)
1
1 buyer  ·  $285  ·  open-market only
Current Price
$0.09
CAD  ·  5-min cache
Market Cap
$13M
CAD  ·  TMX
Lobbying & Contracts
None
0 regs  ·  0 contracts
Energy on Form55: 59% hit rate · +3.6% alpha vs XIU.TO · 68 closed signals Track Record →
Signal Analyst
The Confluence Score and insider trade feed above are free. Signal Analyst adds the full component breakdown, lobbying registrations, and contract wins — plus alerts when this company's signal moves, so you don't have to keep checking back.
Monitor — CAD $29/mo
Price Chart
12 months daily  ·  TSXV:STND
Insider Transactions
90-day window  ·  3 filings
Date Insider Role Nature Dir. Shares Buy Price Return Value
Jun 30, 2026 Engdahl, Douglas Gordon Open Market Sell 1,000,000 $0.10 $100K
Jun 30, 2026 Engdahl, Douglas Gordon Open Market Sell 500,000
May 01, 2026 Krywaniuk, Alicia Lyn Open Market Buy 3,000 $0.10 -10.5%  · 71d $285
Score uses open-market buys only  ·  1 open-market  ·  Return is unrealized, to today's price; a “· Nd” mark means the 90-day window is still open (N of 90 days) — too early to judge.
Score Breakdown
Signal Analyst  ·  $29/mo
Component Points Max Detail Weight
Conviction (unique buyers)  ✓ FREE PREVIEW 30 30 1 unique buyer (maximum conviction)
Buy/sell ratio 20 33% buys (1B / 2S)
Dollar value 25 $285
Lobbying activity 15 None
Contract wins 10 None
Insider track record 10 No track record data
Private placements 8 None
Confluence bonus 10 None
Cluster timing (velocity) 10 No coordinated buying cluster detected
Buy/sell reversal pattern 8 No buy/sell reversal pattern
Total 0 100
Unlock Component Detail — CAD $29/mo
Buying Insiders
Open-market · 90 days · 1 unique buyer
Insider Credibility Hit Rate Avg 90d Return Trades (eval'd) Buy Value (90d) Last Buy
Krywaniuk, Alicia Lyn $285 May 01, 2026
Credibility score: historical hit rate × avg 90d return × sample size. View full insider leaderboard →
Lobbying Registrations
OCL active  ·  none found
No active OCL lobbying registrations in the last 90 days. Analyst plan →
Government Contract Wins
90-day window  ·  none found
No government contract wins in the last 90 days. Analyst plan →
Private Placements
12 months  ·  Signal Analyst  ·  $29/mo
Private placement history, deal size, and lock-up expiry tracking. Analyst plan →
Indigenous Consultation
no records on file

No Indigenous consultation records on file for STND.

SEDAR+ Filings
official filing registry
Form55 monitors SEDAR+ filing alerts and newswire announcements for Technical Reports and material changes. Search SEDAR+ →
Short Interest
CIRO  ·  Jun 30, 2026
Shares short
10,896
Net change
-104,317 (-90.5%)
History
Jun 30: 10,896
Jun 15: 115,213
May 31: 23,253
May 15: 47,889
Apr 30: 93,871
Apr 15: 58,337
Aggregate short position from CIRO's Consolidated Short Position Report (published twice monthly).
Boardroom Connections
7 insiders also active elsewhere
Insider Other boards Also an insider at
McGrath, Sean 4 TORR (80), AUAU (60), SM (41), VENT
Ainsworth, Garrett Paul 3 DMX (55), AUGC, MANU
Chuang, Vivien Wei-Li 3 BLU (55), PRG, AAZ
Engdahl, Douglas Gordon 2 SASK (70), DAU
Jordan, Lloyd Blair 1 GGA
Bey, Jonathan Ian 1 OPHR
McCallum, Neil 1 QTWO
People who file as insiders here and at other TSX/TSXV companies (number in brackets = that company's Confluence Score). A well-connected insider taking a seat at a new junior can be an early tell. Matched by name across SEDI filings; funds and 10%+ holders excluded.
Form55 provides data and analysis for informational purposes only. Nothing on this site constitutes investment advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.